[CYCC] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -77.54%
YoY- -21.48%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -4,165 -3,182 -2,537 -2,452 -1,510 -2,752 -2,174 54.19%
Tax -687 -378 -281 -286 -290 -449 -273 84.90%
NP -3,478 -2,804 -2,256 -2,166 -1,220 -2,303 -1,901 49.53%
Tax Rate - - - - - - - -
Total Cost 3,478 2,804 2,256 2,166 1,220 2,303 1,901 49.53%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 0.00 -47,711,417,389,824.74 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.50 -0.57 -0.46 -0.56 -1.42 -2.68 -2.21 -62.83%
EPS Diluted -0.50 -0.57 -0.46 -0.56 -1.42 -2.68 -2.21 -62.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.